IMMUNOMODULATORY AGENT, CANCER AGENT AND HEALTHY FOOD CONTAINING MONOACETYLDIACYLGLYCERIN DERIVATIVES Russian patent published in 2008 - IPC A61K31/22 A61P37/02 A61P31/18 A61P35/00 A61P29/00 

FIELD: medicine.

SUBSTANCE: oral introduction of monoacetyldiacylglycerin derivatives detains development of hamster's induced cancer by activation of lymphocytes, monocytes and dendritic cells, as well as apoptosis induction of cancer cells owing to intensified cytotoxicity of immune cells in relation to cancer cells. Besides, induction of septic shock at mice is accompanied with shown 100% survival rate even in 120 hours, reached by immunity control and suppressing apoptosis effect. Monoacetyldiacylglycerin derivatives according to this invention can be effectively applied as agent for sepsis and cancer treatment and as healthy food preventing cancer or autoimmune diseases.

EFFECT: discovers application of monoacetyldiacylglycerin derivatives extracted from antler as agent suppressing cell abnormality resulted from autoresponse.

11 cl, 16 dwg, 11 ex, 6 tbl